Abstract FR:

Intestinal barrier is regulated in part by tight junctions (Ds) which are multiprotein structures. Recent studies have suggested that an increased intestinal permeability is involved in the pathophysiology of several intestinal bowel diseases. We aimed to study underlying mechanisms involved in the regulation of three tight junction (Lis) proteins, claudin-1, occludin and ZO-1 in colonic biopsies of IBS patients and in experimental models of Methotrexate (MTX)-induced intestinal mucositis. In addition, we also evaluated the effects of amino acids on MTX-treated models. In colonic mucosa of patients with IBS, we have shown alterations of claudin-1, occludin II proteins in IBS patients with differences according to the IBS subsets and symptoms, specifically, in IBS patients with predominant diarrhea. This suggested that these changes may be involved in the pathophysiology of IBS. In a rodent model of mucositis, we observed that the increase of intestinal permeability induced by MTX, related in part to alteration of T. 's, ZO-1, occludin and claudin-1 proteins expression and cellular distribution. The in vitro data suggest that not only NF-KB, but also MEK1 &2 and INK pathways are involved in the gut barrier disruption induced by MTX. Glutamine supplementation limited the increase of chemotherapy-induced intestinal permeability and restored the expression of proteins of tight junctions probably via the erk and NF-x_13 pathways. Combined glutamine and arginine seemed associated with a stronger mortality. Further studies are needed to confirm the preventive andlor therapeutic interest of the glutamine.